Signify Premium Insights - Medical Imaging: Round-up from January 2025
Signify Research Ltd
Reliable market data you can trust, insightful analysis and exceptional Analyst support.
Written by Phil Grainger | Editor of Signify Premium Insights – Medical Imaging.
This article provides several links to our Signify Premium Insights, evaluating recent mergers and news events. To access these articles, you will need a subscription or simply request 30 days of unlimited access below.
2025 is now well underway, and the medical imaging industry has already had a busy start to the year. In January, the SPI Medical Imaging team covered a range of key developments, including acquisitions, a notable new product launch, and the strategic moves of major market players.
We began the year with a two-part Insight outlining the key trends set to shape the medical imaging market in 2025 across both modalities and IT & AI.
We explore the shifting competitive dynamics, market consolidation, and technological advancements that will shape the year to come.??
英伟达 has been in the spotlight this year, not least due to the impact of the rivalry between OpenAI and DeepSeek AI on its stock price. However, the big tech giant’s recent acquisition of VinBrain, a Vietnam-based medical imaging AI vendor, also caught our attention.
The move represents a significant departure from NVIDIA’s typical AI strategy, positioning it directly in the healthcare application market. Our Insight examines its motivations for the acquisition and its interest in Vietnam.?
ONRAD ’s acquisition of Direct Radiology from 飞利浦 also piqued our interest. Teleradiology is booming, particularly in the US, and this move will position ONRAD as the largest independent teleradiology provider in the country.
Our Insight explores why investment in the sector is surging (including recent rounds such as ￡11.2 million for Hexarad and €10 million for DEEPLINK MEDICAL , in partnership with IMADIS Groupe ), the implications of this deal alongside I-MED Radiology Network ’s acquisition of StatRad in 2024, and why Philips has opted to exit the market now.?
Casting our attention back to December, we assess the buzz surrounding RadNet ’s subsidiary DeepHealth and the range of announcements it made at RSNA 2024, including collaborations with CARPL - Radiology AI Platform and 西门子医疗 .
Our Insight explores the impact of these moves, DeepHealth’s unique market position, and its potential to reshape the outpatient imaging sector.?
LG电子 also revealed an interesting strategic move at Radiological Society of North America (RSNA) 2024, previewing its prototype C-arm X-ray system. With its recent expansion into pathology AI, LG appears to be making a stronger push into medtech.
Our Insight examines how its trajectory compares to 飞利浦 and 三星电子 , and what it will take for the company to establish itself as a serious healthcare player.?
Lung cancer remains the leading cause of cancer-related deaths worldwide, according to the World Health Organization , and screening programmes are becoming a major focus for healthcare policymakers and industry stakeholders.
In an Insight highlighting some of the key developments over the course of 2024, including contextflow ’s notable radiology AI reimbursement contract with IKK Südwest, we consider the commercial impact for hardware and software vendors, and whether 2025 could be a turning point for lung cancer screening.?
Finally, in an Ask the Analyst Insight, Aiyana Amess discusses the evolving ultrasound AI market.
While strong year-on-year growth is projected, vendors continue to face barriers to adoption and commercialisation. Amess explains why diversification – in both payment models and deployment methods – is becoming increasingly critical and why robust evidence and education will be key to driving adoption.
About Signify Premium Insights - Medical Imaging
A subscription to Signify Premium Insights - Medical Imaging provides compelling thought leadership on the most pertinent developments in healthcare technology. This service utilises Signify Research’s expansive market data to properly appraise and interpret breaking news stories, major market moves and industry-changing announcements are evaluated as they unfold, and the considered opinions of Signify Research’s expert analysts are shared to provide insight into current developments. Key vendors, technologies and conferences are followed, with updates carefully scrutinised to ensure that the most important details are revealed and properly assessed.?Subscription provides approximately 100 actionable and up-to-the-moment Premium Insights per year as well as access to Signify’s Insight archive.
These expert insights provide you with an extension to your market research team and provides the knowledge to:
About Phil Grainger | Editor of Signify Premium Insights – Medical Imaging
领英推荐
Phil joined Signify Research in 2023 as Editor for the Signify Premium Insights – Medical Imaging service. He has over 15 years’ experience in editorial and related roles, with a focus on corporate law and finance.
About the Signify Premium Insights Contributing Analysts
Signify Premium Insights rely heavily on the industry expertise from Signify Research’s expert medical imaging analyst team. This team brings with it many years of experience developing market reports, insights and providing consultancy services to the medical imaging industry.
Kelly Patrick | Research Director
Kelly joined Signify Research in 2020 as a Principal Analyst. She brings with her 12 years’ experience covering a range of healthcare technology research. Prior to joining Signify Research she was the manager of the Healthcare Technology team at Omdia (previously known as the Healthcare Technology team at IHS Markit/InMedica). Kelly is now a research Director leading the management of the research teams within the Clinical Care and Medical Imaging groups. Kelly’s core research focus has been on the clinical care space, including patient monitoring, anaesthesia, sleep & respiratory care, and infusion. Kelly has been the lead on several large custom and consulting projects, specialising on in-depth analysis across the clinical care and wider healthcare technology space. Prior to entering the market research industry, Kelly also gained experience in consulting projects on pricing and reimbursement for pharmaceuticals and was a research analyst for a large research contractor, specialising in immunoassay techniques.
Bhvita Jani | Principal Analyst
Bhvita joined Signify Research in 2020 as part of the Medical Imaging Team focusing on the X-ray market. She brings with her 3 years’ experience covering X-ray, MRI and CT research at IHS Markit. Bhvita also has three years’ experience in digital and offline marketing.
Amy Thompson | Research Manager
Amy joined Signify Research in 2020, and is now the Research Manager for Healthcare IT, focusing on imaging and clinical IT, AI in medical imaging and teleradiology. Prior to Signify Research, she brings four years’ experience as a Senior Analyst; supporting business strategy and market sizing for Liaison Group, a company operating within the NHS.
Mustafa Hassan, PhD | Senior Market Analyst
Mustafa joined Signify Research in 2020 as part of the Medical Imaging team which covers areas such as ultrasound, general radiography and machine learning in medical imaging. Prior to that he obtained a PhD in Pharmacy and Physiology from the University of Kent.
Aiyana Amess | Market Analyst
Aiyana joined Signify Research in 2023 as part of the Medical Imaging team. She graduated from Loughborough University with a BSC in Medicinal and Pharmaceutical Chemistry, receiving a diploma in industrial studies after completing an internship at Roche.
Poornima Anil | Senior Market Analyst
Poornima joined Signify Research’s Medical Imaging Team in 2023. She brings over 14 years’ of experience in healthcare market research, analysis and business intelligence. She has a Master’s degree in bioinformatics.
Max Street | Market Analyst
Having graduated from the University of Bristol with a BSc in Pharmacology, Max joined the Medical Imaging team at Signify Research in 2023, focusing on the X-ray market.
S-J James | Senior Market Analyst
Sarah-Jane joined Signify Research as a Senior Market Analyst in 2024 as part of the Medical Imaging team. She has previously held roles at Fitch Solutions, Citeline and Environment Analyst, and has over four years of experience working in healthcare market intelligence. She also holds a BSc in Molecular Biology from the University of Manchester.
About Signify Research
Signify Research provides healthtech market intelligence powered by data that you can trust. We blend insights collected from in-depth interviews with technology vendors and healthcare professionals with sales data reported to us by leading vendors to provide a complete and balanced view of the market trends. Our coverage areas are Medical Imaging, Clinical Care, Digital Health, Diagnostic and Lifesciences, Healthcare IT and AI in Healthcare.
Clients worldwide rely on direct access to our expert Analysts for their opinions on the latest market trends and developments. Our market analysis reports and subscriptions provide data-driven insights which business leaders use to guide strategic decisions. We also offer custom research services for clients who need information that can’t be obtained from our off-the-shelf research products or who require market intelligence tailored to their specific needs.
If you’ve enjoyed this Round-up, then follow our Signify Research page and sign up for further free monthly Medical Imaging market intelligence insights.
#medicalimaging #healthtech #marketintelligence #medicalimagingtrends #signifyresearch